Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 25, 2019

SELL
$76.06 - $120.81 $37,421 - $59,438
-492 Closed
0 $0
Q1 2018

Apr 20, 2018

SELL
$107.21 - $151.94 $1,715 - $2,431
-16 Reduced 3.15%
492 $55,000
Q4 2017

Jan 23, 2018

SELL
$118.58 - $151.28 $13,162 - $16,792
-111 Reduced 17.93%
508 $75,000
Q3 2017

Oct 23, 2017

BUY
$114.6 - $136.81 $70,937 - $84,685
619
619 $72,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.